ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37342
-0.13%
Bitcoin
66,852.55
0.32%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. PhaseBio Pharmaceuticals Inc (CE) (PHASQ)

  7. PhaseBio Pharmaceuticals Inc (CE) (PHASQ) News

PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PHASQ
DateTimeSourceHeadlineSymbolCompany
05/16/20243:32PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/16/20243:28PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
11/29/20233:55PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
11/15/20233:17PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
10/03/20236:17AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
09/27/20237:52AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
08/25/202311:34AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
08/25/202311:31AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
06/30/20233:21PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/30/20233:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/19/20233:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/19/20233:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/19/20233:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/19/20233:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
05/16/20233:23PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
04/03/20233:06PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
03/24/20237:08AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
02/14/20234:07PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
02/14/20232:01PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
02/14/20231:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
12/23/20227:34AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
12/21/20225:10AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
12/02/20223:20PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
11/15/20223:21PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
11/04/20223:44PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PHASQPhaseBio Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:PHASQ

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
HHSE
Hannover House (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
CIVX
CTR Investments and Cons... (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
RNVA
Rennova Health (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
SPZI
Spooz (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
RONN
Ronn Motor (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved